To establish reliable image maps of these pathologies, we used FDG-18 (glucose metabolism), AV-45 (Aβ), and AV-1451 (Tau) PET scans from the large ADNI cohort of AD and CN subjects. Here, MAPT is linked to Alzheimer disease.